ipharmaservices
European Society of Cardiology Congress | 2024 | #ESCCoggress2024 | iPharmaCenter
Long-Term Follow-Up of Phase 3 Study Highlights Efficacy and Safety of Camzyos in Symptomatic Obstructive Hypertrophic Cardiomyopathy An...
top of page
Search
bottom of page